Joe Biden (Credit: Doug Mills/The New York Times/Bloomberg via Getty Images)

Covid-19 man­u­fac­tur­ing roundup: Biden dou­bles down on vac­ci­na­tion plan with 100M-dose or­der; BioN­Tech, Pfiz­er ready to in­crease man­u­fac­tur­ing; J&J ex­pe­ri­ences de­liv­ery woes

With head­lines around the globe fo­cused on var­i­ous hitch­es in the glob­al sup­ply chain for Covid vac­cines, Pres­i­dent Joe Biden is tak­ing out an in­sur­ance pol­i­cy of sorts to help guar­an­tee his promise to rapid­ly ex­pand ac­cess.

Ear­li­er in the week the pres­i­dent an­nounced plans for a new con­tract with J&J cov­er­ing an added 100 mil­lion dos­es of their one-shot jab to guard against Covid-19, to be de­liv­ered in the sec­ond half of the year. And much of that work will be done at Mer­ck’sDurham, NC fa­cil­i­ty, which re­cent­ly an­nounced plans to ex­pand its work­force by 100 at the 900,000-square-foot plant.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.